Analysts anticipate Medpace Hldgs to report an earnings per share (EPS) of $3.54.
Investors in Medpace Hldgs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Historical Earnings Performance
In the previous earnings release, the company beat EPS by $0.11, leading to a 54.67% increase in the share price the following trading session.
Here's a look at Medpace Hldgs's past performance and the resulting price change:
Quarter
Q2 2025
Q1 2025
Q4 2024
Q3 2024
EPS Estimate
2.99
3.08
3.12
2.78
EPS Actual
3.10
3.67
3.67
3.01
Price Change %
55.00
-2.00
-8.00
-7.00
Stock Performance
Shares of Medpace Hldgs were trading at $544.41 as of October 20. Over the last 52-week period, shares are up 65.62%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analyst Views on Medpace Hldgs
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Medpace Hldgs.
Analysts have given Medpace Hldgs a total of 11 ratings, with the consensus rating being Neutral. ...